WO1995002060A1 - Plants having modified growth characteristics - Google Patents
Plants having modified growth characteristics Download PDFInfo
- Publication number
- WO1995002060A1 WO1995002060A1 PCT/GB1994/001465 GB9401465W WO9502060A1 WO 1995002060 A1 WO1995002060 A1 WO 1995002060A1 GB 9401465 W GB9401465 W GB 9401465W WO 9502060 A1 WO9502060 A1 WO 9502060A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plants
- plant
- phytoene synthase
- tom5
- growth characteristics
- Prior art date
Links
- 230000012010 growth Effects 0.000 title claims abstract description 24
- 101710173432 Phytoene synthase Proteins 0.000 claims abstract description 60
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 22
- 108020004414 DNA Proteins 0.000 claims abstract description 19
- 239000002299 complementary DNA Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 13
- 230000009466 transformation Effects 0.000 claims description 7
- 101000764239 Homo sapiens Mitochondrial import receptor subunit TOM5 homolog Proteins 0.000 claims 2
- 102100026902 Mitochondrial import receptor subunit TOM5 homolog Human genes 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 27
- 108090000790 Enzymes Proteins 0.000 abstract description 24
- 102000004190 Enzymes Human genes 0.000 abstract description 24
- 235000021466 carotenoid Nutrition 0.000 abstract description 21
- 150000001747 carotenoids Chemical class 0.000 abstract description 20
- 230000002829 reductive effect Effects 0.000 abstract description 19
- 230000034303 cell budding Effects 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 description 124
- 240000003768 Solanum lycopersicum Species 0.000 description 23
- 108090000623 proteins and genes Proteins 0.000 description 21
- 229930191978 Gibberellin Natural products 0.000 description 20
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 20
- 239000003448 gibberellin Substances 0.000 description 20
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 19
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical class C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 19
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 17
- 230000014509 gene expression Effects 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 14
- 230000037361 pathway Effects 0.000 description 14
- OINNEUNVOZHBOX-XBQSVVNOSA-N Geranylgeranyl diphosphate Natural products [P@](=O)(OP(=O)(O)O)(OC/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)O OINNEUNVOZHBOX-XBQSVVNOSA-N 0.000 description 13
- 108020004999 messenger RNA Proteins 0.000 description 13
- 238000003786 synthesis reaction Methods 0.000 description 13
- 235000013399 edible fruits Nutrition 0.000 description 12
- OINNEUNVOZHBOX-KGODAQDXSA-N geranylgeranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C\CC\C(C)=C\CO[P@@](O)(=O)OP(O)(O)=O OINNEUNVOZHBOX-KGODAQDXSA-N 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 230000002018 overexpression Effects 0.000 description 11
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 10
- 230000008635 plant growth Effects 0.000 description 10
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 9
- 235000011765 phytoene Nutrition 0.000 description 9
- 101150112180 tom5 gene Proteins 0.000 description 9
- 230000009261 transgenic effect Effects 0.000 description 9
- 239000013598 vector Substances 0.000 description 9
- 239000005980 Gibberellic acid Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 108700019146 Transgenes Proteins 0.000 description 7
- 230000005070 ripening Effects 0.000 description 7
- 238000013518 transcription Methods 0.000 description 7
- 230000035897 transcription Effects 0.000 description 7
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 239000005648 plant growth regulator Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 150000003505 terpenes Chemical class 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000035784 germination Effects 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 235000002566 Capsicum Nutrition 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 3
- 239000006002 Pepper Substances 0.000 description 3
- 235000016761 Piper aduncum Nutrition 0.000 description 3
- 240000003889 Piper guineense Species 0.000 description 3
- 235000017804 Piper guineense Nutrition 0.000 description 3
- 235000008184 Piper nigrum Nutrition 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 238000012300 Sequence Analysis Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 235000012661 lycopene Nutrition 0.000 description 3
- 239000001751 lycopene Substances 0.000 description 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 3
- 229960004999 lycopene Drugs 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- -1 terpenoid quinones Chemical class 0.000 description 3
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- RVCNKTPCHZNAAO-UZDKSQMHSA-N (1R,2R,3R)-prephytoene diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\[C@@H]1[C@@H](COP(O)(=O)OP(O)(O)=O)[C@]1(C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C RVCNKTPCHZNAAO-UZDKSQMHSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- OINNEUNVOZHBOX-QIRCYJPOSA-K 2-trans,6-trans,10-trans-geranylgeranyl diphosphate(3-) Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP([O-])(=O)OP([O-])([O-])=O OINNEUNVOZHBOX-QIRCYJPOSA-K 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000002567 Capsicum annuum Nutrition 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 241000053208 Porcellio laevis Species 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 230000008238 biochemical pathway Effects 0.000 description 2
- 239000001511 capsicum annuum Substances 0.000 description 2
- 108010067758 ent-kaurene oxidase Proteins 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 description 2
- 238000003976 plant breeding Methods 0.000 description 2
- 239000003375 plant hormone Substances 0.000 description 2
- 210000002706 plastid Anatomy 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 1
- RMOGWMIKYWRTKW-UONOGXRCSA-N (S,S)-paclobutrazol Chemical compound C([C@@H]([C@@H](O)C(C)(C)C)N1N=CN=C1)C1=CC=C(Cl)C=C1 RMOGWMIKYWRTKW-UONOGXRCSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- JLIDBLDQVAYHNE-LXGGSRJLSA-N 2-cis-abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\C1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-LXGGSRJLSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 108700005084 Multigene Family Proteins 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000005985 Paclobutrazol Substances 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000191023 Rhodobacter capsulatus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000009134 cell regulation Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 230000000497 effect on colour Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 230000007773 growth pattern Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical group CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000013138 pruning Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 150000003735 xanthophylls Chemical class 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8249—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving ethylene biosynthesis, senescence or fruit development, e.g. modified tomato ripening, cut flower shelf-life
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- This invention relates to the use of recombinant DNA technology to control the growth of plants.
- gibberellin hormone group plant growth regulators expressed naturally within plants
- European Application Publication Number 212822 describes use of an inhibitor of gibberellin synthesis to control tree height.
- a major group of gibberellin pathway inhibitors are those which function as kaurene oxidase inhibitors, for example 1- (4-chlorophenyl) -4,4-dimethyl-2- (1H-1, 2,4-triazol -l-y)pentan-3-ol and stereoisomers thereof including paclobutrazol .
- the plant growth regulator may have a number of beneficial effects: it may reduce the stomatal aperture and influence the stomata's ability to close; it may produce thicker guard cell membranes; it may produce better formed chloroplasts,* it may provide thicker cuticular wax; it may stimulate root formation and favourable root habit; it may have a greening effect; it may provide more numerous and better developed leaf hairs; it may reduce internodal length, providing a more favourable habit in the mature plant; it may ensure that leaf number and size are normal; it may protect from frost damage.
- Plants in which gibberellin biosynthesis has been inhibited show a reduction in height, which may be due to reduced elongation of the stem internodes. Other effects on growth may include altered branching and budding patterns. Traditional plant breeding is also used to obtain such dwarf plant varieties adapted for certain purposes.
- the ability to produce dwarf plants is particularly useful in certain circumstances. For example, it provides a means to adapt a plant to its environment (for example, so it will not outgrow its limited space and resources) ; to improve or control the shape, size and appearance of ornamental plants (including pot plants, shrubs and trees) ; to reduce the need for or frequency of trimming or pruning (for example, for trees growing beneath overhead power cables) ; to increase stand strength (for example, plants with shorter stems may be less susceptible to wind damage or lodging) ; and/or to improve the viability of young plants during micro-propagation. Plants contain a wide range of biochemicals (including plant growth regulators) which have a direct or indirect effect on phenotype.
- Gibberellins are isoprenoids and are known to share a common early pathway with other biologically important isoprenoids such as sterols, terpenoid quinones and carotenoids (See Figure 1 in Bramley and Mackenzie, 1988, Current Topics in Cellular Regulation, 29:291-343).
- Carotenoids include a range of biochemicals such as carotenes, lutein, xanthophylls, and pigments such as lycopene.
- the biosynthesis of carotenoids in higher plants and micro-organisms has been the subject of numerous investigations.
- the pathways of carotenoid biosynthesis across a range of organisms share many common features (Bramley and Mackenzie, 1988) .
- the biochemical pathway leading to carotenoid biosynthesis is shown in Figure 1.
- the divergence to the dedicated pathway for carotenoid synthesis is after the formation of geranylgeranyl diphosphate (GGDP - previously known as geranylgeranyl pyrophosphate, GGPP) .
- the first unique step in the formation of carotenoids is the head-to-head condensation of 2 molecules of GGDP to form the first C _ carotenoid, phytoene.
- the synthesis of phytoene from GGDP involves two reaction steps with prephytoene diphosphate (PPDP - previously known as prephytoene pyrophosphate, PPPP) as the intermediate, but both reactions are catalysed by a single enzyme in plants and micro ⁇ organisms.
- This enzyme which catalyses the conversion of GGDP to phytoene, is known as phytoene synthase (Bramley et al, 1992, Plant Journal, 2:343-349).
- Phytoene synthase activity has been detected in a wide range of plant species including tomato, pepper, maize, carrot, spinach and tobacco. There are many similarities between the enzymes from different species.
- the enzymes are located in the plastid stroma and synthesise the same phytoene sterio-isomer (15-cis phytoene) .
- the enzymes all require Mn as a co-factor although the requirement for ATP is unclear.
- DNA sequences encoding phytoene synthase enzymes are known.
- the TOM5 gene encodes an enzyme involved in the ripening of tomatoes (Ray e_t al, 1987, Nucleic Acids Research, 15:10587) which has been identified as the enzyme phytoene synthase (international patent application published as WO91/09128; international patent application published as W092/16635) .
- Phytoene synthase enzymes show sequence similarity.
- the molecular weight of the purified pepper (Capsicum annuum) phytoene synthase (48kD) (described by Dogbo et al 1988) is very similar to the predicted molecular weight of the mature phytoene synthase protein encoded by T0M5 (47.6kD) . Alignment of the predicted phytoene synthase protein sequences from Arabidopsis and pepper cDNA clones with the predicted protein sequence of the tomato phytoene synthase encoded by TOM5 shows 72% and 85% homology respectively.
- the protein encoded by the tomato TOM5 cDNA also shows significant homology (27% identity; 17% similarity) to the CrtB protein from Rhodobacter capsulatus, a gram-negative purple bacterium (Armstrong et al, 1990, JBC, 265:8329- 8338) .
- the CrtB protein catalyses the conversion of GGDP to phytoene (Bartley GE et al, 1992, J Biological Chem, 267:5036-5039) .
- Tomato contains at least one other locus with homology to TOM5.
- TOM5 cDNA will cross-hybridise with two clones: the genomic clone known as Clone F (Ray et al, 1992, PMB, 19:401-404) and the cDNA clone known as Psy2 (Bartley and Scolnik, 1993, J Biol Chem, 268:25718-25721) .
- Psy2 has 80% overall nucleotide homology to TOM5 cDNA.
- the TOM5 cDNA sequence has also been used as a hybridisation probe to identify phytoene synthase clones from other species, including Capsicum annuum which has 83% overall homology (Romer et al, 1993, Biochem Biophys Res Commun, 196:1414-1421) and Arabidopsis thaliana which has 65% overall homology (Scolnik and Bartley, 1994, Plant Physiology, 104:1471-1472) .
- TOM5 enzyme phytoene synthase
- constructs which contain DNA homologous to the substantially complete gene.
- promotion of lycopene production may be brought about by inserting one or more functional copies of the T0M5 cDNA, or of the full-length TOM5 gene, under control of a functional plant promoter into a tomato plant to give fruit of a deeper red colour.
- Fray and Grierson (1993, Plant Mol Biol, 22:589-602) discuss the over-expression of plant phytoene synthase genes in tomato and the effect on colour.
- a method to produce plants having modified growth characteristics which comprises transformation of target plants with a DNA construct including a DNA sequence expressing phytoene synthase, growth of transformed plants, and selection of plants having modified growth characteristics.
- the invention further provides a plant having modified growth characteristics which comprises a plant cell transformed with a DNA construct including a DNA sequence expressing phytoene synthase, and the progeny and seed of such a plant.
- a dwarf plant is defined as a plant having reduced height compared with an untransformed plant of the same genotype. This may be due to reduced elongation of the stem internodes.
- the plant may also show other modified growth characteristics, such as an altered pattern of branching or budding.
- Transformation with suitable DNA constructs results in over-expression of the phytoene synthase enzyme in the target plant which has a surprising phenotypic effect on plant stature: the transgenic plants have reduced height and a general dwarf structure.
- manipulation of a plant to over-express an enzyme of carotenoid biosynthesis unexpectedly produces a plant with altered growth characteristics similar to those of a plant in which gibberellin levels are reduced.
- Over-expression of the phytoene synthase enzyme may be achieved by: introduction of a phytoene synthase gene into a plant cell where the enzyme is not naturally expressed; introduction of one or more extra phytoene synthase genes into a plant so that it contains multiple copies of the gene; enhancing expression of the phytoene synthase gene (for example, the promoter may be selected to give a higher degree of expression than is given by the natural phytoene synthase promoter) .
- the promoter may be selected to give a higher degree of expression than is given by the natural phytoene synthase promoter
- TOM5-encoded phytoene synthase in transgenic plants and their descendants may be used to modify plant growth characteristics of any plant species.
- Phytoene synthase-encoding sequences derived from other plant species may similarly be used.
- the method according to the invention provides the ability to produce dwarf plants without the need to apply exogenous agrochemicals. Although it is possible to breed the reduced stature trait into plants using traditional methods, the present invention provides a means of transferring the trait into elite lines without a prolonged breeding programme which might alter other desirable traits at the same time.
- transformation with various phytoene synthase constructs has a range of effects on plant growth characteristics. For example, if phytoene synthase expression is inhibited by insertion of antisense or partial sense ' genes into the plant, it is possible to select transformants having modified growth characteristics consistent with those expected in a plant with elevated levels of the plant hormone gibberellin (such as increased height, precocious germination) .
- the target plant cell may be part of a whole plant or may be an isolated cell or part of a tissue which may be regenerated into a whole plant.
- the target plant cell may be selected from any monocotyledonous or dicotyledonous plant species. Suitable plants include fruit-bearing plants (such as tomato, peaches) , vegetables (such as potatoes) , other crop plants (such as corn, wheat, rice, sorghum, other cereals, oil seed rape, sunflower) , ornamental plants (including shrubs and trees) , and other tree species (including timber species such as pine, trees used for paper making such as eucalyptus and poplar) . Application of the method is not limited to the species listed above.
- the method according to the invention may be advantageously applied to potatoes.
- Inhibiting gibberellic acid (GA) is believed to promote tuber formation (Vreugdenhil and Helder, 1991, Progress in Plant Growth Regulation, Kluwer Academic Press, London, p393-400) .
- Sprouting of mature/stored tubers may also be inhibited in plants with reduced GA levels.
- lycopene production involving the phytoene synthase enzyme, may occur in the tuber plastids
- lycopene production involving the phytoene synthase enzyme
- Both monocotyledonous and dicotyledonous plant cells may be transformed in various ways known to the art .
- plant cells may be cultured to regenerate whole plants which subsequently reproduce to give successive generations of genetically modified plants .
- Any suitable method of plant transformation may be used.
- dicotyledonous plants may be transformed by Agrobacterium Ti plasmid technology, such as described by Bevan (1984, Nucleic Acid Research, 12:8711-8721) .
- the transformed plants may be reproduced sexually (selfed or crossed) or by cell or tissue culture.
- the transgenic plants may be used to generate one or more generations of descendants.
- the dwarf transgenic plants may be introduced into standard plant breeding programmes. Some of these descendants will display modified growth characteristics and may be selected on the basis of this phenotype.
- the DNA construct used for transformation includes a DNA sequence encoding the functional phytoene synthase enzyme and a transcriptional initiation region (or promoter) operative in plants, so that the construct can generate mRNA in plant cells.
- constitutive promoters such as the 35S cauliflower mosaic virus promoter
- inducible or developmentally regulated promoters such as the CAB promoter driving expression in green tissues
- Use of a constitutive promoter will tend to affect functions in all parts of the plant, while use of a tissue specific promoter allows more selective control of gene expression and affected functions.
- Use of the phytoene synthase gene promoter itself (International application W092/16635) , at least in tomatoes, has the advantage that the production of increased amounts of the enzyme occurs at a time when carotenoids are normally synthesised.
- Plant growth characteristics may be modified to a greater or lesser extent by controlling the degree of mRNA production in the plant cells. This may be done by suitable choice of promoter sequences, or by selecting the number of copies or the site of integration of the phytoene synthase DNA sequences that are introduced into the plant genome.
- the DNA construct may include more than one DNA sequence encoding phytoene synthase or more than one recombinant construct may be transformed into each plant cell.
- a suitable cDNA or genomic DNA or synthetic polynucleotide may be used as a source of the DNA base sequence for transcription. It is convenient to use a cDNA clone as the DNA sequence.
- T0M5 cDNA inserted into plasmid pT0M5
- This clone was deposited as a plasmid in E.coli on 1 September 1989 under the terms of the Budapest Treaty at the National Collections of Industrial and Marine Bacteria (23 St. Machar Drive, Aberdeen, AB2 1RY, Scotland) and was given the reference NCIB 40191.
- a cDNA clone similar to pTOM5 may alternatively be obtained from the mRNA of ripening tomatoes by the method described by Slater et al (1985, Plant Molecular Biology, 5:137-147) .
- An alternative source of DNA for the base sequence for transcription is a suitable gene encoding the phytoene synthase.
- This gene may differ from the cDNA in that introns may be present .
- the introns are not transcribed into mRNA (or, if so transcribed, are subsequently cut out) .
- the TOM5 gene was deposited as a plasmid (gTOM5) in phage 1 EMBL3 on 11 March 1991 under the terms of the Budapest Treaty at the National Collections of Industrial and Marine Bacteria (23 St.
- the preferred DNA sequence for use in the present invention is DNA derived from the cDNA clone pTOM5 or the genomic clone gTOM5 or a synthetic polynucleotide based on the pTOM5/gTOM5 sequence.
- suitable genes may be isolated from other plant species or from bacteria, yeast, lower and higher eukaryotes.
- the complete cDNA sequence or the complete gene sequence as found in the chromosome of the plant may be used.
- Recombinant DNA constructs may be made using standard techniques.
- the DNA sequence for transcription (encoding phytoene synthase) may be obtained by treating a vector containing said sequence (such as pTOM5) with restriction enzymes to cut out the appropriate segment.
- the DNA sequence for transcription may also be generated by annealing and ligating synthetic oligonucleotides or by using synthetic oligonucleotides in a polymerase chain reaction (PCR) to give suitable restriction sites at each end.
- PCR polymerase chain reaction
- Suitable promoters include the 35S cauliflower mosaic virus promoter and the tomato polygalacturonase gene promoter sequence (Bird et. al, 1988, Plant Molecular Biology, 11:651-662) .
- Suitable terminator sequences include that of the Agrobacterium tumefaciens nopaline synthase gene (the nos 3' end) .
- FIG. 1 shows the pathway of carotenoid biosynthesis.
- Figure 2 is a diagram showing the construction of a phytoene synthase over-expression vector, pBDH5ST.
- Figure 3 is a graph showing the height of transgenic seedlings.
- Figure 4 is a diagram showing part of the isoprenoid pathway.
- Figure 5 is a graph showing the mean internode lengths of homozygous, hemizygous and azygous plants.
- Figure 6 is a graph showing the levels of gibberellins in a control plant and a transformant.
- Figure 7 is a graph showing the level of GA1 in a control plant and a transformant.
- the cDNA clone pTOM5 encodes (almost completely) a plant gene which expresses an enzyme involved in the ripening of tomatoes (Ray et al, 1987, Nucleic Acids Research, 15:10587) .
- pTOM5 was derived from a cDNA library isolated from ripe tomato RNA (Slater et al, 1985, Plant Molecular Biology, 5:137-147) .
- Three other clones (pTOM45, pTOM91, pTOM104) from the same library cross-hybridise to pTOM5 and probably contain related sequences.
- pTOM5 has been characterised by hybrid select translation to encode a protein of approximately 48kD.
- pJRl (Smith et al, 1988, Nature, 3.34.:724-726) is a Binl9 ( Bevan, 1984, Nucleic Acids Research, 12 . :8711-8721) based vector which permits the expression of the pTOM5 RNA under the control of the CaMV 35S promoter and has a nopaline synthase (nos) 3' end termination sequence. After synthesis, the vectors with the sense orientation of pTOM5 sequence were identified by DNA sequence analysis. This vector was called pJR15CS.
- Figure 2 is a diagram showing the construction of the phytoene synthase over-expression vector, pBDH5ST.
- the Sspl fragment of pTOM5 was cloned into Smal-cut pT7T3c ⁇ l8 to form the vector pT7T3TOM5.
- pT7T3TOM5 was sequentially treated with EcoRI, Klenow then BamHI to remove the TOM5 insert .
- This was ligated into pDH51 (previously treated with Sail, Klenow and BamHI) to form the vector pDH5ST (CaMV 35S promoter and terminator) .
- the EcoRI fragment from pDH5ST was cloned into the EcoRI site of pBIN19 to form pBDH5ST.
- the pBDH5ST-type construct is more effective in producing the dwarf phenotype.
- pBDH5ST vectors were transferred to Agrobacterium tumefaciens LBA4404 and used to transform tomato plants. Transformation of tomato stem segments followed standard protocols (Bird et al, 1988, Plant Molecular Biology, 11:651-662) . Transformed plants were identified by their ability to grow on media containing the antibiotic kanamycin. Plants were regenerated and grown to maturity.
- Transformed plants showing the altered growth phenotype were selected.
- the introduced TOM5-derived construct expresses phytoene synthase. At the same time, it may cause some suppression of the endogenous phytoene synthase (TOM5) gene.
- a larger proportion of the transformed plants may be dwarf if co-suppression were prevented so that reproducibly high levels of enzyme over-expression could be obtained.
- Co-suppression in tomato may not occur if a phytoene synthase gene from a different organism were used in the construct.
- the selected dwarf transgenic plants show an altered growth habit (reduced height, reduced internode lengths) .
- the selected plants also showed the following characteristics: the seeds germinated more slowly (germination of the seeds can be improved by pre-treatment with sodium hypochlorite; alternatively germination may be improved by pre-treatment with gibberellin) ; the roots of the germinating seedlings had a pale pink/red colour; the seedlings were shorter.
- Table 1 compares the phenotype of one of the homozygous dwarf lines (designated BDH5STB) with an azygous plant derived from the progeny of the same primary transformant. TABLE 1
- Table 2 shows measurements from mature 5 month old plants of the dwarf line BDH5STB and of a second dwarf line BDH5ST:Z171. (Internodes are numbered down from the apex and distances are in millimetres) . This data demonstrates the reduced internode lengths. The dwarf phenotype is quite obvious, with a mean reduction of slightly greater than ten fold for internodes 3-6.
- Transgenic tomato plants have been produced in which transcription of a fruit phytoene synthase cDNA, TOM5 (containing all of the translated sequence) , is driven by a constitutive CaMV 35S promoter. Some of these plants were capable of producing a functional phytoene synthase protein as judged by their ability to complement a naturally deficient mutant and by the increased carotenoid content of immature fruit and senescent leaves of both mutant and wild type plants carrying the transgene. ' Over-expression of phytoene synthase in some plants altered hormone synthesis resulting in dwarfing.
- FIG. 3 is a graph showing the height of seedlings from seven different transgenic lines (labelled Z171 D3-E9) .
- the seedlings from line D9 showed approximately the same height and growth pattern as those of wild type (AC++) .
- the seedlings from line D4 were taller than the control. However, the seedlings from lines D3, D5, E3, E4 and E9 showed varying degrees of retarded growth relative to those* of wild type (AC++) .
- the dwarf phenotype persisted through at least four months growth and an apparent loss of apical dominance occurred in some cases, leading to a bushy phenotype.
- Leaf size was also reduced.
- Similar phenotypes (though varying in severity) have been found in the progeny of several independently transformed over-expressing lines, both of transgenic wild-type and yellowflesh mutant plants. This dwarf phenotype is similar to that seen in plants that have been treated with inhibitors of gibberellic acid synthesis.
- the isoprenoid pathway produces the precursors of three major classes of plant growth regulators - cytokinins, gibberellins (GA) and abscisic acid (ABA) .
- Figure 4 illustrates part of this pathway.
- Many plant volatiles are due to terpenes and the phytol side chain of chlorophyll is also formed from isoprenoid units. Altering the metabolism of any intermediate in this pathway may have profound effects on the levels of many important plant products.
- a detailed analysis of the dwarf plants expressing the TOM5 construct is currently underway. However, the synthesis of phytoene from two molecules of geranylgeranyl diphosphate could redirect pools of this precursor away from the synthesis of gibberellins.
- FIG. 5 is a graph showing the mean internode lengths of homozygous plants (highest level of TOM5 mRNA) , hemizygous plants (intermediate level of TOM5 mRNA) and azygous plants (no TOM5 transgene mRNA) .
- Figure 6 is a graph showing the levels of different gibberellins (GAs) in a control plant and a line expressing a phytoene synthase transgene (BDH5ST) .
- GAs gibberellins
- BDH5ST phytoene synthase transgene
- This phenotype could be explained if the inhibition of an endogenous phytoene synthase has resulted in more available geranylgeranyl diphosphate which in turn has been converted to various gibberellins.
- the germination rate of seeds from the sense-suppressed plants was increased and on occasion germination actually occurred within the fruit.
- Increased GA or decreased ABA may play a role in such a phenotype.
Abstract
To produce plants having modified growth characteristics, target plants are transformed with a DNA construct including a DNA sequence encoding phytoene synthase, an enzyme involved in carotenoid biosynthesis. From the transformants, plants which have modified growth characteristics are selected. Such plants may have a reduced height compared with an untransformed plant or may show other modified growth characteristics, such as an altered pattern of branching or budding.
Description
PLANTS HAVING MODIFIED GROWTH CHARACTERISTICS
This invention relates to the use of recombinant DNA technology to control the growth of plants.
The use of agrochemicals to alter plant growth characteristics is known. Such chemicals are exogenously applied to the plant and act as plant growth regulators. Many interfere with production of the gibberellin hormone group (plant growth regulators expressed naturally within plants) to obtain the desired effects on plant stature. For example, European Application Publication Number 212822 describes use of an inhibitor of gibberellin synthesis to control tree height. A major group of gibberellin pathway inhibitors are those which function as kaurene oxidase inhibitors, for example 1- (4-chlorophenyl) -4,4-dimethyl-2- (1H-1, 2,4-triazol -l-y)pentan-3-ol and stereoisomers thereof including paclobutrazol . The biochemical and biological effects of kaurene oxidase inhibitors have been described by Dalziel et al in British Plant Growth Regul Group, 1984, 11 (biochem aspects synth nat occurring plant growth regul) , p43-57 (Chem Abs, 1985, 102(3) :249, abstract no 19513r) . European Application Publication Number 252617 describes the use of plant growth regulators which inhibit the gibberellin pathway to improve the viability of plantlets on transfer from in vitro micropropagation conditions to in vivo conditions. The plant growth regulator may have a number of beneficial effects: it may reduce the stomatal aperture and influence the stomata's ability to close; it may produce thicker guard cell membranes;
it may produce better formed chloroplasts,* it may provide thicker cuticular wax; it may stimulate root formation and favourable root habit; it may have a greening effect; it may provide more numerous and better developed leaf hairs; it may reduce internodal length, providing a more favourable habit in the mature plant; it may ensure that leaf number and size are normal; it may protect from frost damage.
Plants in which gibberellin biosynthesis has been inhibited show a reduction in height, which may be due to reduced elongation of the stem internodes. Other effects on growth may include altered branching and budding patterns. Traditional plant breeding is also used to obtain such dwarf plant varieties adapted for certain purposes.
The ability to produce dwarf plants is particularly useful in certain circumstances. For example, it provides a means to adapt a plant to its environment (for example, so it will not outgrow its limited space and resources) ; to improve or control the shape, size and appearance of ornamental plants (including pot plants, shrubs and trees) ; to reduce the need for or frequency of trimming or pruning (for example, for trees growing beneath overhead power cables) ; to increase stand strength (for example, plants with shorter stems may be less susceptible to wind damage or lodging) ; and/or to improve the viability of young plants during micro-propagation.
Plants contain a wide range of biochemicals (including plant growth regulators) which have a direct or indirect effect on phenotype. Gibberellins are isoprenoids and are known to share a common early pathway with other biologically important isoprenoids such as sterols, terpenoid quinones and carotenoids (See Figure 1 in Bramley and Mackenzie, 1988, Current Topics in Cellular Regulation, 29:291-343). Carotenoids include a range of biochemicals such as carotenes, lutein, xanthophylls, and pigments such as lycopene. The biosynthesis of carotenoids in higher plants and micro-organisms has been the subject of numerous investigations. The pathways of carotenoid biosynthesis across a range of organisms share many common features (Bramley and Mackenzie, 1988) . The biochemical pathway leading to carotenoid biosynthesis is shown in Figure 1.
The divergence to the dedicated pathway for carotenoid synthesis is after the formation of geranylgeranyl diphosphate (GGDP - previously known as geranylgeranyl pyrophosphate, GGPP) . The first unique step in the formation of carotenoids is the head-to-head condensation of 2 molecules of GGDP to form the first C _ carotenoid, phytoene. The synthesis of phytoene from GGDP involves two reaction steps with prephytoene diphosphate (PPDP - previously known as prephytoene pyrophosphate, PPPP) as the intermediate, but both reactions are catalysed by a single enzyme in plants and micro¬ organisms. This enzyme, which catalyses the conversion of GGDP to phytoene, is known as phytoene synthase (Bramley et al, 1992, Plant Journal, 2:343-349).
Phytoene synthase activity has been detected in a wide range of plant species including tomato, pepper, maize, carrot, spinach and tobacco. There are many similarities between the enzymes from different species. The enzymes are located in the plastid stroma and synthesise the same phytoene sterio-isomer (15-cis phytoene) . The enzymes all require Mn as a co-factor although the requirement for ATP is unclear.
DNA sequences encoding phytoene synthase enzymes are known. For example, the TOM5 gene encodes an enzyme involved in the ripening of tomatoes (Ray e_t al, 1987, Nucleic Acids Research, 15:10587) which has been identified as the enzyme phytoene synthase (international patent application published as WO91/09128; international patent application published as W092/16635) . Phytoene synthase enzymes show sequence similarity. The molecular weight of the purified pepper (Capsicum annuum) phytoene synthase (48kD) (described by Dogbo et al 1988) is very similar to the predicted molecular weight of the mature phytoene synthase protein encoded by T0M5 (47.6kD) . Alignment of the predicted phytoene synthase protein sequences from Arabidopsis and pepper cDNA clones with the predicted protein sequence of the tomato phytoene synthase encoded by TOM5 shows 72% and 85% homology respectively. The protein encoded by the tomato TOM5 cDNA also shows significant homology (27% identity; 17% similarity) to the CrtB protein from Rhodobacter capsulatus, a gram-negative purple bacterium (Armstrong et al, 1990, JBC, 265:8329- 8338) . The CrtB protein catalyses the conversion of GGDP to phytoene (Bartley GE et al, 1992, J Biological Chem, 267:5036-5039) .
There is homology between plant phytoene synthase DNA sequences. Tomato contains at least one other locus with homology to TOM5. TOM5 cDNA will cross-hybridise with two clones: the genomic clone known as Clone F (Ray et al, 1992, PMB, 19:401-404) and the cDNA clone known as Psy2 (Bartley and Scolnik, 1993, J Biol Chem, 268:25718-25721) . Psy2 has 80% overall nucleotide homology to TOM5 cDNA. The TOM5 cDNA sequence has also been used as a hybridisation probe to identify phytoene synthase clones from other species, including Capsicum annuum which has 83% overall homology (Romer et al, 1993, Biochem Biophys Res Commun, 196:1414-1421) and Arabidopsis thaliana which has 65% overall homology (Scolnik and Bartley, 1994, Plant Physiology, 104:1471-1472) .
International application WO91/09128 describes "antisense" and "sense" DNA constructs encoding phytoene synthase and their use to modify the synthesis of carotenoid compounds in plants. These DNA constructs comprise a DNA sequence homologous to some or all of the TOM5 gene, preceded by a transcriptional initiation region operative in plants so that the construct can generate mRNA in plant cells. The DNA construct may encode mRNA which can be translated to give the enzyme produced by the TOM5 gene. International application WO91/09128 describes a method for modifying the production of carotenoids in plants by transforming such plants with the aforementioned DNA constructs, and also describes transformed plants (and their descendants) having a modified carotenoid content. Generally, production of the TOM5 enzyme (phytoene synthase) within the plant is enhanced by
constructs which contain DNA homologous to the substantially complete gene. For example, promotion of lycopene production may be brought about by inserting one or more functional copies of the T0M5 cDNA, or of the full-length TOM5 gene, under control of a functional plant promoter into a tomato plant to give fruit of a deeper red colour. Fray and Grierson (1993, Plant Mol Biol, 22:589-602) discuss the over-expression of plant phytoene synthase genes in tomato and the effect on colour.
In summary, international application WO91/09128 describes the control of TOM5 gene expression in plants (using recombinant DNA technology) to modify colour production and certain other related functions (β-carotene and Vitamin A production; protection against high light intensity damage; control of sporopollenin synthesis and pollen formation/maturation) . We have now observed that over-expression of the TOM5 gene product may affect the growth of plants (a function which is apparently unrelated to the role of the TOM5 gene product) .
According to the invention, there is provided a method to produce plants having modified growth characteristics which comprises transformation of target plants with a DNA construct including a DNA sequence expressing phytoene synthase, growth of transformed plants, and selection of plants having modified growth characteristics.
The invention further provides a plant having modified growth characteristics which comprises a plant cell transformed with a DNA
construct including a DNA sequence expressing phytoene synthase, and the progeny and seed of such a plant.
The method according to the invention is particularly useful for producing dwarf plants. A dwarf plant is defined as a plant having reduced height compared with an untransformed plant of the same genotype. This may be due to reduced elongation of the stem internodes. The plant may also show other modified growth characteristics, such as an altered pattern of branching or budding.
Transformation with suitable DNA constructs results in over-expression of the phytoene synthase enzyme in the target plant which has a surprising phenotypic effect on plant stature: the transgenic plants have reduced height and a general dwarf structure. Thus, manipulation of a plant to over-express an enzyme of carotenoid biosynthesis unexpectedly produces a plant with altered growth characteristics similar to those of a plant in which gibberellin levels are reduced.
Over-expression of the phytoene synthase enzyme may be achieved by: introduction of a phytoene synthase gene into a plant cell where the enzyme is not naturally expressed; introduction of one or more extra phytoene synthase genes into a plant so that it contains multiple copies of the gene; enhancing expression of the phytoene synthase gene (for example, the promoter may be selected to give a higher degree of expression than is given by the natural phytoene synthase promoter) .
For increased expression of phytoene synthase activity, it is necessary to produce an active protein that catalyses the correct chemical reaction and is directed to the correct location within the cell. Since there is considerable biochemical and sequence similarity between phytoene synthases from different plant species, production of the TOM5-encoded phytoene synthase in transgenic plants and their descendants may be used to modify plant growth characteristics of any plant species. Phytoene synthase-encoding sequences derived from other plant species (for example, those isolated using TOM5 as a probe) may similarly be used.
The method according to the invention provides the ability to produce dwarf plants without the need to apply exogenous agrochemicals. Although it is possible to breed the reduced stature trait into plants using traditional methods, the present invention provides a means of transferring the trait into elite lines without a prolonged breeding programme which might alter other desirable traits at the same time.
International application WO91/09128 demonstrated that the pathway of carotenoid biosynthesis can be effectively regulated by either down-regulating or over-expressing the phytoene synthase enzyme encoded by TOM5. The present invention relates to the use of a DNA construct encoding phytoene synthase to alter plant growth characteristics. Apparently the plant responds to phytoene synthase over-expression by altering the pathway leading to gibberellin production even though said enzyme is not directly involved in the
biosynthesis of said plant hormone. As part of the biochemical pathway leading to carotenoid synthesis, mevalonic acid is converted into geranylgeranyl diphosphate (GGDP) . This substrate is used for the synthesis of both coloured carotenoids and gibberellins. Thus the over-expression of phytoene synthase in the carotenoid pathway may alter the levels of GGDP such that the synthesis of gibberellins is reduced.
Observations have shown that transformation with various phytoene synthase constructs has a range of effects on plant growth characteristics. For example, if phytoene synthase expression is inhibited by insertion of antisense or partial sense'genes into the plant, it is possible to select transformants having modified growth characteristics consistent with those expected in a plant with elevated levels of the plant hormone gibberellin (such as increased height, precocious germination) .
The target plant cell may be part of a whole plant or may be an isolated cell or part of a tissue which may be regenerated into a whole plant. The target plant cell may be selected from any monocotyledonous or dicotyledonous plant species. Suitable plants include fruit-bearing plants (such as tomato, peaches) , vegetables (such as potatoes) , other crop plants (such as corn, wheat, rice, sorghum, other cereals, oil seed rape, sunflower) , ornamental plants (including shrubs and trees) , and other tree species (including timber species such as pine, trees used for paper making such as eucalyptus and poplar) . Application of the method is not limited to the species listed above.
For example, the method according to the invention may be advantageously applied to potatoes. Inhibiting gibberellic acid (GA) is believed to promote tuber formation (Vreugdenhil and Helder, 1991, Progress in Plant Growth Regulation, Kluwer Academic Press, London, p393-400) . Sprouting of mature/stored tubers may also be inhibited in plants with reduced GA levels. (In addition, lycopene production, involving the phytoene synthase enzyme, may occur in the tuber plastids) .
Both monocotyledonous and dicotyledonous plant cells may be transformed in various ways known to the art . In many cases such plant cells may be cultured to regenerate whole plants which subsequently reproduce to give successive generations of genetically modified plants . Any suitable method of plant transformation may be used. For example, dicotyledonous plants may be transformed by Agrobacterium Ti plasmid technology, such as described by Bevan (1984, Nucleic Acid Research, 12:8711-8721) .
The transformed plants may be reproduced sexually (selfed or crossed) or by cell or tissue culture. Thus the transgenic plants may be used to generate one or more generations of descendants. For example, the dwarf transgenic plants may be introduced into standard plant breeding programmes. Some of these descendants will display modified growth characteristics and may be selected on the basis of this phenotype.
The DNA construct used for transformation includes a DNA sequence encoding the functional phytoene synthase enzyme and a transcriptional initiation region (or promoter) operative in plants, so that the construct can generate mRNA in plant cells. Both constitutive promoters (such as the 35S cauliflower mosaic virus promoter) and inducible or developmentally regulated promoters (such as the CAB promoter driving expression in green tissues) may be used as circumstances require. Use of a constitutive promoter will tend to affect functions in all parts of the plant, while use of a tissue specific promoter allows more selective control of gene expression and affected functions. Use of the phytoene synthase gene promoter itself (International application W092/16635) , at least in tomatoes, has the advantage that the production of increased amounts of the enzyme occurs at a time when carotenoids are normally synthesised.
Plant growth characteristics may be modified to a greater or lesser extent by controlling the degree of mRNA production in the plant cells. This may be done by suitable choice of promoter sequences, or by selecting the number of copies or the site of integration of the phytoene synthase DNA sequences that are introduced into the plant genome. For example, the DNA construct may include more than one DNA sequence encoding phytoene synthase or more than one recombinant construct may be transformed into each plant cell.
As a source of the DNA base sequence for transcription, a suitable cDNA or genomic DNA or synthetic polynucleotide may be used.
It is convenient to use a cDNA clone as the DNA sequence. For example, the base sequence of T0M5 cDNA (inserted into plasmid pT0M5) is disclosed in Ray et. al, 1987, Nucleic Acids Research, 15:10587 and in international application WO91/09128. This clone was deposited as a plasmid in E.coli on 1 September 1989 under the terms of the Budapest Treaty at the National Collections of Industrial and Marine Bacteria (23 St. Machar Drive, Aberdeen, AB2 1RY, Scotland) and was given the reference NCIB 40191. A cDNA clone similar to pTOM5 may alternatively be obtained from the mRNA of ripening tomatoes by the method described by Slater et al (1985, Plant Molecular Biology, 5:137-147) .
An alternative source of DNA for the base sequence for transcription is a suitable gene encoding the phytoene synthase. This gene may differ from the cDNA in that introns may be present . The introns are not transcribed into mRNA (or, if so transcribed, are subsequently cut out) . When using such a gene as the source of a partial base sequence for transcription it is possible to use either intron or exon regions. For example, the TOM5 gene was deposited as a plasmid (gTOM5) in phage 1 EMBL3 on 11 March 1991 under the terms of the Budapest Treaty at the National Collections of Industrial and Marine Bacteria (23 St. Machar Drive, Aberdeen, AB2 1RY, Scotland) and was given the reference NCIMB 40382. International Patent Publication number W092/16635 discloses the structure of the TOM5 gene and nucleotide sequences of the 3.5 kb EcoRI - Sail fragment and the 3' region of the gTOM5 phytoene synthase gene.
A further way of obtaining a suitable DNA base sequence for transcription is to synthesise it ab initio from the appropriate bases, for example using the pTOM5 or gTOM5 sequences as a guide.
The preferred DNA sequence for use in the present invention is DNA derived from the cDNA clone pTOM5 or the genomic clone gTOM5 or a synthetic polynucleotide based on the pTOM5/gTOM5 sequence. However, other sources of phytoene synthase genes may also be used as suitable genes may be isolated from other plant species or from bacteria, yeast, lower and higher eukaryotes.
To obtain vectors suitable for expression of the functional phytoene synthase in plant cells, the complete cDNA sequence or the complete gene sequence as found in the chromosome of the plant may be used. Recombinant DNA constructs may be made using standard techniques. For example, the DNA sequence for transcription (encoding phytoene synthase) may be obtained by treating a vector containing said sequence (such as pTOM5) with restriction enzymes to cut out the appropriate segment. The DNA sequence for transcription may also be generated by annealing and ligating synthetic oligonucleotides or by using synthetic oligonucleotides in a polymerase chain reaction (PCR) to give suitable restriction sites at each end. The DNA sequence is then cloned into a second vector containing the desired upstream promoter and downstream terminator sequences. Suitable promoters include the 35S cauliflower mosaic virus promoter and the tomato polygalacturonase gene promoter sequence (Bird et. al, 1988, Plant
Molecular Biology, 11:651-662) . Suitable terminator sequences include that of the Agrobacterium tumefaciens nopaline synthase gene (the nos 3' end) .
The invention will now be described by way of example only with reference to the accompanying drawings, in which:
Figure 1 shows the pathway of carotenoid biosynthesis.
Figure 2 is a diagram showing the construction of a phytoene synthase over-expression vector, pBDH5ST.
Figure 3 is a graph showing the height of transgenic seedlings.
Figure 4 is a diagram showing part of the isoprenoid pathway.
Figure 5 is a graph showing the mean internode lengths of homozygous, hemizygous and azygous plants.
Figure 6 is a graph showing the levels of gibberellins in a control plant and a transformant.
Figure 7 is a graph showing the level of GA1 in a control plant and a transformant.
EXAMPLE 1 Characterisation of the TOM5 phytoene synthase gene family.
The cDNA clone pTOM5 encodes (almost completely) a plant gene which expresses an enzyme involved in the ripening of tomatoes (Ray et al, 1987, Nucleic Acids Research, 15:10587) . pTOM5 was derived from a cDNA library isolated from ripe tomato RNA (Slater et al, 1985, Plant Molecular
Biology, 5:137-147) . Three other clones (pTOM45, pTOM91, pTOM104) from the same library cross-hybridise to pTOM5 and probably contain related sequences. pTOM5 has been characterised by hybrid select translation to encode a protein of approximately 48kD. DNA sequence analysis has demonstrated that the clone is 1600 bases long with an open reading frame encoding a polypeptide of 46.7kD. The mRNA for which pTOM5 codes is expressed in ripening tomato fruit. No expression could be detected in green fruit. pT0M5 is expressed most strongly at the full orange stage of ripening. The level of mRNA then declines in line with the general decline in biosynthetic capacity of the ripening fruit. Expression of pTOM5 mRNA could also be induced by exposing mature green fruit to exogenous ethylene. The expression of pTOM5 is reduced in the Ripening inhibitor (rin) and Neverripe (Nr) tomato fruit ripening mutants which mature very slowly, and never achieve the full red colour associated with ordinary tomato fruit.
Biochemical experiments have established that the pT0M5 gene product is the phytoene synthase enzyme (international application W092/16635) . Tomatoes in which the expression of the pTOM5 gene was inhibited using antisense RNA no longer accumulate carotenoids, in particular phytoene. Biochemical feeding experiments with these tomatoes demonstrated that phytoene synthase was inhibited in the fruit.
International application W092/16635 describes the isolation of pT0M5-related genes. The genomic locations in the tomato of sequences homologous to
pT0M5 were identified using RFLP mapping: two loci, on chromosome 2 and chromosome 3 respectively, carry sequences homologous to pTOM5. It was also shown by Southern blotting that the gene may be present as a small multigene family. Genomic clones representing two individual genes were isolated and characterised by DNA sequence analysis. The clone gTOM5 represents part of a gene with exon sequence identical to pTOM5. Clone F contains a sequence similar, but not identical to pTOM5. The genomic clones cover most of the coding region and the complete transcriptional initiation region of the phytoene synthase gene.
EXAMPLE 2 Construction of phytoene synthase over-expression vectors with the CaMV 35S promoter
(a) PJR15CS
Bases 1 to 1598 (the complete cDNA) of pTOM5 were made into a PCR-generated fragment digested with Kpnl and BamHI . The cut ends were made flush with T4 polymerase and then cloned into the Hindi site of pJRl. pJRl (Smith et al, 1988, Nature, 3.34.:724-726) is a Binl9 ( Bevan, 1984, Nucleic Acids Research, 12.:8711-8721) based vector which permits the expression of the pTOM5 RNA under the control of the CaMV 35S promoter and has a nopaline synthase (nos) 3' end termination sequence. After synthesis, the vectors with the sense orientation of pTOM5 sequence were identified by DNA sequence analysis. This vector was called pJR15CS.
(b) PBDH5ST
Figure 2 is a diagram showing the construction of the phytoene synthase over-expression vector, pBDH5ST.
The Sspl fragment of pTOM5 was cloned into Smal-cut pT7T3cϋl8 to form the vector pT7T3TOM5. pT7T3TOM5 was sequentially treated with EcoRI, Klenow then BamHI to remove the TOM5 insert . This was ligated into pDH51 (previously treated with Sail, Klenow and BamHI) to form the vector pDH5ST (CaMV 35S promoter and terminator) . The EcoRI fragment from pDH5ST was cloned into the EcoRI site of pBIN19 to form pBDH5ST.
The pBDH5ST-type construct is more effective in producing the dwarf phenotype.
EXAMPLE 3 Generation of transformants and selection of dwarf plants
pBDH5ST vectors were transferred to Agrobacterium tumefaciens LBA4404 and used to transform tomato plants. Transformation of tomato stem segments followed standard protocols (Bird et al, 1988, Plant Molecular Biology, 11:651-662) . Transformed plants were identified by their ability to grow on media containing the antibiotic kanamycin. Plants were regenerated and grown to maturity.
Transformed plants showing the altered growth phenotype (dwarf plants with reduced internode lengths) were selected.
The introduced TOM5-derived construct expresses phytoene synthase. At the same time, it may cause some suppression of the endogenous phytoene synthase (TOM5) gene. A larger proportion of the transformed plants may be dwarf if co-suppression were prevented so that reproducibly high levels of enzyme over-expression could be obtained. Co-suppression in tomato may not occur if a phytoene synthase gene from a different organism were used in the construct.
EXAMPLE 4 Analysis of dwarf plants
The selected dwarf transgenic plants show an altered growth habit (reduced height, reduced internode lengths) . In general, the selected plants also showed the following characteristics: the seeds germinated more slowly (germination of the seeds can be improved by pre-treatment with sodium hypochlorite; alternatively germination may be improved by pre-treatment with gibberellin) ; the roots of the germinating seedlings had a pale pink/red colour; the seedlings were shorter.
Table 1 compares the phenotype of one of the homozygous dwarf lines (designated BDH5STB) with an azygous plant derived from the progeny of the same primary transformant.
TABLE 1
Table 2 shows measurements from mature 5 month old plants of the dwarf line BDH5STB and of a second dwarf line BDH5ST:Z171. (Internodes are numbered down from the apex and distances are in millimetres) . This data demonstrates the reduced internode lengths. The dwarf phenotype is quite obvious, with a mean reduction of slightly greater than ten fold for internodes 3-6.
TABLE 2
Other dwarf lines showed more severe dwarfing and large numbers of seedlings from three different lines are being germinated for additional synchronised measurements.
EXAMPLE 5 Further analysis of dwarf plants
Transgenic tomato plants have been produced in which transcription of a fruit phytoene synthase cDNA, TOM5 (containing all of the translated sequence) , is driven by a constitutive CaMV 35S promoter. Some of these plants were capable of producing a functional phytoene synthase protein as judged by their ability to complement a naturally deficient mutant and by the increased carotenoid content of immature fruit and senescent leaves of
both mutant and wild type plants carrying the transgene. ' Over-expression of phytoene synthase in some plants altered hormone synthesis resulting in dwarfing. Internode length was much reduced (resulting in dwarf plants) : a six week old seedling that over-expresses the TOM5 transgene was shorter than a wild type plant of similar age. Figure 3 is a graph showing the height of seedlings from seven different transgenic lines (labelled Z171 D3-E9) . The seedlings from line D9 showed approximately the same height and growth pattern as those of wild type (AC++) . The seedlings from line D4 were taller than the control. However, the seedlings from lines D3, D5, E3, E4 and E9 showed varying degrees of retarded growth relative to those* of wild type (AC++) . The dwarf phenotype persisted through at least four months growth and an apparent loss of apical dominance occurred in some cases, leading to a bushy phenotype. Leaf size was also reduced. Similar phenotypes (though varying in severity) have been found in the progeny of several independently transformed over-expressing lines, both of transgenic wild-type and yellowflesh mutant plants. This dwarf phenotype is similar to that seen in plants that have been treated with inhibitors of gibberellic acid synthesis.
The isoprenoid pathway produces the precursors of three major classes of plant growth regulators - cytokinins, gibberellins (GA) and abscisic acid (ABA) . Figure 4 illustrates part of this pathway. Many plant volatiles are due to terpenes and the phytol side chain of chlorophyll is also formed from isoprenoid units. Altering the metabolism of any intermediate in this pathway may have profound
effects on the levels of many important plant products. A detailed analysis of the dwarf plants expressing the TOM5 construct is currently underway. However, the synthesis of phytoene from two molecules of geranylgeranyl diphosphate could redirect pools of this precursor away from the synthesis of gibberellins. If increased levels of phytoene result in an increased flux through the down stream pathway, higher levels of abscisic acid might also result. Reduced gibberellins and/or increased abscisic acid levels may be the primary cause of the observed dwarf phenotypes. Preliminary measurements indicate that gibberellins are reduced and abscisic is increased in tissues from these dwarf plants. The severity of the stunted phenotype correlates well with the level of expression of the transgene as determined by mRNA analysis. The degree of internode shortening in mature plants correlates well with the level of expression (as determined by northern analysis) of the TOM5 transgene in homozygous, hemizygous and azygous progeny of a primary transformant containing a single insert. Figure 5 is a graph showing the mean internode lengths of homozygous plants (highest level of TOM5 mRNA) , hemizygous plants (intermediate level of TOM5 mRNA) and azygous plants (no TOM5 transgene mRNA) .
Figure 6 is a graph showing the levels of different gibberellins (GAs) in a control plant and a line expressing a phytoene synthase transgene (BDH5ST) . Several gibberellins were reduced in TOM5 over-expressers, including a 30-fold reduction in the active GA (shown by the graph in Figure 7) .
Other (non-dwarf) transformants in which the presence of the transgene (TOM5 constructs) resulted in co-suppression of the fruit, flower and leaf phytoene synthase genes, had a growth habit with some characteristics of GA treated plants. They were taller than control plants and had thinner, more fragile stems with longer internode distances. This phenotype could be explained if the inhibition of an endogenous phytoene synthase has resulted in more available geranylgeranyl diphosphate which in turn has been converted to various gibberellins. The germination rate of seeds from the sense-suppressed plants was increased and on occasion germination actually occurred within the fruit. Increased GA or decreased ABA may play a role in such a phenotype.
Claims
1. A method to produce plants having modified growth characteristics which comprises transformation of target plants with a DNA construct including a DNA sequence expressing phytoene synthase, growth of transformed plants, and selection of plants having modified growth characteristics.
2. A method as claimed in claim 1 in which the plants having modified growth characteristics are dwarf plants.
3. A method as claimed in either claim 1 or claim 2 in which the DNA sequence is a TOM5 sequence.
. A method as claimed in claim 3 in which the DNA sequence is a TOM5 cDNA sequence.
5. A plant having modified growth characteristics which comprises a plant cell transformed with a DNA construct including a DNA sequence expressing phytoene synthase.
6. A plant as claimed in claim 5 which is a dwarf plant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU70799/94A AU7079994A (en) | 1993-07-09 | 1994-07-07 | Plants having modified growth characteristics |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9314261.0 | 1993-07-09 | ||
GB939314261A GB9314261D0 (en) | 1993-07-09 | 1993-07-09 | Dwarf plants |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995002060A1 true WO1995002060A1 (en) | 1995-01-19 |
Family
ID=10738567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1994/001465 WO1995002060A1 (en) | 1993-07-09 | 1994-07-07 | Plants having modified growth characteristics |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU7079994A (en) |
GB (1) | GB9314261D0 (en) |
WO (1) | WO1995002060A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997029123A2 (en) * | 1996-02-12 | 1997-08-14 | Plant Bioscience Limited | Nucleic acid encoding gai gene of arabidopsis thaliana |
WO1997046690A1 (en) * | 1996-06-07 | 1997-12-11 | Zeneca Limited | Enhancement of gene expression |
WO1999006579A2 (en) * | 1997-07-30 | 1999-02-11 | Instituut Voor Agrobiologisch En Bodemvruchtbaarheidsonderzoek (Ab-Dlo) | Inhibition of unwanted hormone action in plants |
WO1999009174A1 (en) * | 1997-08-13 | 1999-02-25 | Plant Bioscience Limited | Genetic control of plant growth and development |
WO2000000598A2 (en) * | 1998-06-26 | 2000-01-06 | The University Of Leicester | Plant dwarfing |
WO2000009722A2 (en) * | 1998-08-10 | 2000-02-24 | Monsanto Company | Methods for controlling gibberellin levels |
US9175301B2 (en) | 2009-07-24 | 2015-11-03 | Pioneer Hi Bred International Inc | Use of dimerization domain component stacks to modulate plant architecture |
WO2016089931A1 (en) * | 2014-12-03 | 2016-06-09 | Monsanto Technology Llc | Transgenic plants with enhanced traits |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991009128A1 (en) * | 1989-12-13 | 1991-06-27 | Imperial Chemical Industries Plc | Dna, constructs, cells and plants derived therefrom |
WO1991013078A1 (en) * | 1990-03-02 | 1991-09-05 | Amoco Corporation | Biosynthesis of carotenoids in genetically engineered hosts |
WO1992016635A1 (en) * | 1991-03-14 | 1992-10-01 | Imperial Chemical Industries Plc | Expression of genes in transgenic plants |
-
1993
- 1993-07-09 GB GB939314261A patent/GB9314261D0/en active Pending
-
1994
- 1994-07-07 AU AU70799/94A patent/AU7079994A/en not_active Abandoned
- 1994-07-07 WO PCT/GB1994/001465 patent/WO1995002060A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991009128A1 (en) * | 1989-12-13 | 1991-06-27 | Imperial Chemical Industries Plc | Dna, constructs, cells and plants derived therefrom |
WO1991013078A1 (en) * | 1990-03-02 | 1991-09-05 | Amoco Corporation | Biosynthesis of carotenoids in genetically engineered hosts |
WO1992016635A1 (en) * | 1991-03-14 | 1992-10-01 | Imperial Chemical Industries Plc | Expression of genes in transgenic plants |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6830930B2 (en) | 1996-02-12 | 2004-12-14 | Pioneer Hi-Bred International, Inc. | Nucleic acid encoding GAI gene of arabidopsis thaliana |
WO1997029123A3 (en) * | 1996-02-12 | 1997-10-09 | Innes John Centre Innov Ltd | Nucleic acid encoding gai gene of arabidopsis thaliana |
WO1997029123A2 (en) * | 1996-02-12 | 1997-08-14 | Plant Bioscience Limited | Nucleic acid encoding gai gene of arabidopsis thaliana |
US6307126B1 (en) | 1996-02-12 | 2001-10-23 | Plant Bioscience Limited | Nucleic acid encoding GAI gene of Arabidopsis thaliana |
US6794560B2 (en) | 1996-02-12 | 2004-09-21 | Pioneer Hi-Bred International, Inc. | Nucleic acid encoding GAI gene of Arabidopsis thaliana |
WO1997046690A1 (en) * | 1996-06-07 | 1997-12-11 | Zeneca Limited | Enhancement of gene expression |
AU726697B2 (en) * | 1996-06-07 | 2000-11-16 | Syngenta Limited | Enhancement of gene expression |
WO1999006579A2 (en) * | 1997-07-30 | 1999-02-11 | Instituut Voor Agrobiologisch En Bodemvruchtbaarheidsonderzoek (Ab-Dlo) | Inhibition of unwanted hormone action in plants |
WO1999006579A3 (en) * | 1997-07-30 | 1999-04-22 | Instituut Voor Agrobiologisch | Inhibition of unwanted hormone action in plants |
WO1999009174A1 (en) * | 1997-08-13 | 1999-02-25 | Plant Bioscience Limited | Genetic control of plant growth and development |
EP1681349A3 (en) * | 1997-08-13 | 2009-07-22 | Pioneer Hi-Bred International, Inc. | Genetic control of plant growth and development |
US7268272B2 (en) | 1997-08-13 | 2007-09-11 | Pioneer Hi-Bred International, Inc. | Genetic control of plant growth and development |
US6762348B1 (en) | 1997-08-13 | 2004-07-13 | Pioneer Hi-Bred International, Inc. | Genetic control of plant growth and development |
WO2000000598A2 (en) * | 1998-06-26 | 2000-01-06 | The University Of Leicester | Plant dwarfing |
WO2000000598A3 (en) * | 1998-06-26 | 2000-02-10 | Univ Leicester | Plant dwarfing |
US6723897B2 (en) | 1998-08-10 | 2004-04-20 | Monsanto Technology, Llc | Methods for controlling gibberellin levels |
WO2000009722A3 (en) * | 1998-08-10 | 2000-09-28 | Monsanto Co | Methods for controlling gibberellin levels |
US7195917B2 (en) | 1998-08-10 | 2007-03-27 | Monsanto Technology Llc | Methods for controlling gibberellin levels |
WO2000009722A2 (en) * | 1998-08-10 | 2000-02-24 | Monsanto Company | Methods for controlling gibberellin levels |
US9175301B2 (en) | 2009-07-24 | 2015-11-03 | Pioneer Hi Bred International Inc | Use of dimerization domain component stacks to modulate plant architecture |
WO2016089931A1 (en) * | 2014-12-03 | 2016-06-09 | Monsanto Technology Llc | Transgenic plants with enhanced traits |
US20170369894A1 (en) * | 2014-12-03 | 2017-12-28 | Monsanto Technology Llc | Transgenic Plants With Enhanced Traits |
US10323253B2 (en) | 2014-12-03 | 2019-06-18 | Monsanto Technology Llc | Transgenic plants with enhanced traits |
US11168333B2 (en) | 2014-12-03 | 2021-11-09 | Monsanto Technology Llc | Transgenic plants with enhanced traits |
Also Published As
Publication number | Publication date |
---|---|
AU7079994A (en) | 1995-02-06 |
GB9314261D0 (en) | 1993-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5304478A (en) | Modification of carotenoid production in tomatoes using pTOM5 | |
Bird et al. | Using antisense RNA to study gene function: inhibition of carotenoid biosynthesis in transgenic tomatoes | |
Fray et al. | Molecular genetics of tomato fruit ripening | |
US5942657A (en) | Co-ordinated inhibition of plant gene expression | |
Frey et al. | Engineering seed dormancy by the modification of zeaxanthin epoxidase gene expression | |
US5908973A (en) | DNA encoding fruit-ripening-related proteins, DNA constructs, cells and plants derived therefrom | |
JP2002051654A (en) | Genetic engineering with new plant expression | |
US5880332A (en) | DNA constructs related to capsanthin capsorubin synthase, cells and plants derived therefrom | |
WO1996002650A2 (en) | Dna, constructs, cells and plants derived therefrom | |
Grierson et al. | Control of ripening in transgenic tomatoes | |
WO1995002060A1 (en) | Plants having modified growth characteristics | |
EA006100B1 (en) | Method of transforming plant cells, accumulating carotenoids, and isolated dna, suitable for carrying out the method | |
Luo et al. | Expression of the ipt gene with the AGPase S1 promoter in tomato results in unbranched roots and delayed leaf senescence | |
Jorgensen et al. | Research note: Maternally-controlled ovule abortion results from cosuppression of dihydroflavonol-4-reductase or flavonoid-3′, 5′-hydroxylase genes in Petunia hybrida | |
GIOVANNONI | Molecular and genetic analysis of tomato fruit development and ripening | |
US6989472B1 (en) | cDNA sequence transcribing an mRNA encoding the terminal oxidase associated with carotenoid biosynthesis, and uses thereof | |
US20050022269A1 (en) | Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof | |
US5569829A (en) | Transformed tomato plants | |
WO2008064413A1 (en) | Plants with hexose accumulating tissues having an altered hexose concentration | |
JP2000513218A (en) | Genetic control of auxin polar transport in plants and manipulation of plant growth, structure and morphogenesis | |
WO1993014212A1 (en) | Transgenic plants with increased solids content | |
Underwood et al. | Petunia biotechnology | |
JP2004520822A (en) | Recombinant plant that mimics the activity of an HP-1 mutant from tomato | |
JPH07155189A (en) | Lycopene cyclase | |
WO1995016047A1 (en) | Ethylene resistant selection system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BB BG BR BY CA CN CZ FI GE HU JP KE KG KP KR KZ LK LT LV MD MG MN MW NO NZ PL RO RU SD SI SK TJ TT UA US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |